MedPath

Rehabilitation in Patients With Human Lymphotropic Virus Type I

Not Applicable
Conditions
Human T-Lymphotropic Virus Type 1 Associated Myelopathy
Interventions
Other: Inspiratory muscle trainning
Other: Exercise
Registration Number
NCT04875403
Lead Sponsor
Universidade Metodista de Piracicaba
Brief Summary

In our times, it is known that approximately 5% of patients seropositive for HTLV-1 may desengage a frame with several neurological disorders, which is called myelopathy associated with HTLV-1, characterized for gait, decreased dynamic balance and limitation of walking independence the use of walkers, crutches as in wheelchairs. This evolution of the disease is based, above all, on muscle changes, such as inflammation of the muscles, which contributes to the attenuation of muscle capacity . In addition, muscle changes caused by HTLV-1 also affect the respiratory muscles, causing a change in respiratory mechanics, which can impair alveolar ventilation and, therefore, the development of a restorative respiratory disorder, reducing total lung capacity. Therefore, it is perceived the importance of offering planned rehabilitation according to the global assessment of the health status of these patients, considering their influence on activities of daily living.The focus of this study is on the weekly respiratory muscle training, as assessed by mensuration maximal inspiratory pressure, showed significant results in improving lung capacity and in this way promoting the prevention of pulmonary complications. Therefore, the protocol proposed by the present study includes respiratory muscular training plus resistance exercise, assessing the impact on both the strength muscular respiratory to as peripheral muscles, through the palmar pressure test and consequent enhancement of quality life and functionality of these patients. Furthermore, it will be possible to contribute to the knowledge of society and the scientific community about this theme, which is still very small in the world literature.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Seropositive carriers for HTLV-1 with PET
Exclusion Criteria
  • lung diseases
  • heart disease
  • arterial hypertension
  • cognitive impairments

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Respiratory muscle training groupInspiratory muscle trainningInspiratory muscle training with linear load device, associated with the resisted training. The initial training load for each participant will be adjusted to 25% of MIP. Each week, the researcher determines the new values for load (1 to week 25%, 2 to week 35%;. 3 to week 40%;. 4 to week 45%;. 5 to week 50%.).The resistance training protocol will consist of the exercises of the front pull, the extension chair and the vertical bench press, covering large muscle groups in the dorsal region of the quadriceps and chest, respectively. Each year consist of three sets of 10 repetitions with a load equivalent to 60% of a test Repetition Maximum (1RM), which will be changed every week (1 to week 60%, 2 to week 65%;. 3 the . week 70%, 4 to week. 75%, 5 to week 80%).
Aerobic exercise groupExerciseExercise bike for 30 minutes, which will be divided into 10 minutes for the foot heating and 20 minutes for the workout aerobic exercise that will have to maintain a target training heart rate, training has to be equivalent to 40% to 60%% target intensity.
Primary Outcome Measures
NameTimeMethod
Respiratory muscular strenghtfrom baseline respiratory muscle stenght to 5 weeks

The assessment of respiratory muscle strength will be carried out weekly by measuring the maximum inspiration pressure

Functional capacityfrom baseline functional capacity to 5 weeks

The assessment of functional capacity will be carried out weekly by six minute walk test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universidade do Estado do Pará

🇧🇷

Belém, Pará, Brazil

© Copyright 2025. All Rights Reserved by MedPath